ISSN: 2167-065X

臨床薬理学および生物薬剤学

オープンアクセス

当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い

オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得

インデックス付き
  • CAS ソース インデックス (CASSI)
  • 索引コペルニクス
  • Google スカラー
  • シェルパ・ロミオ
  • Genamics JournalSeek
  • レフシーク
  • ハムダード大学
  • エブスコ アリゾナ州
  • OCLC-WorldCat
  • パブロン
  • ユーロパブ
  • ICMJE
このページをシェアする

抽象的な

The Crucial Role of Pharmacoeconomics in Healthcare Decision-Making

Nishikawa Makiya

In the complex landscape of modern healthcare, the allocation of limited resources to ensure optimal patient outcomes is a challenging task. Pharmacoeconomics, a discipline at the intersection of economics and pharmacy, plays a pivotal role in guiding healthcare decision-making processes. This abstract explores the essential role of Pharmacoeconomics in shaping healthcare policies and improving patient care.Pharmacoeconomics involves the systematic evaluation of the economic aspects of healthcare interventions, with a primary focus on pharmaceuticals. It employs a variety of tools and methodologies to assess the cost-effectiveness, cost-benefit, and cost-utility of different healthcare options. These evaluations enable healthcare decision-makers, including policymakers, clinicians, and healthcare administrators, to make informed choices regarding resource allocation, treatment selection, and reimbursement decisions. One of the fundamental contributions of Pharmacoeconomics is its ability to provide evidence-based insights into the value of healthcare interventions. By quantifying the costs associated with various treatments and their corresponding health benefits, Pharmacoeconomics analyses help identify interventions that offer the greatest value for money. This information is invaluable for healthcare systems grappling with rising healthcare costs and limited budgets. Pharmacoeconomics serves as a critical tool in the complex process of healthcare decisionmaking. By providing rigorous economic evaluations of healthcare interventions, it empowers stakeholders to make informed choices that optimize resource allocation, improve patient care, and enhance the sustainability of healthcare systems. As the demands on healthcare systems continue to grow, the role of Pharmacoeconomics in shaping the future of healthcare decision-making remains indispensable.